Omv AG OMV ORD SHS/ AT0000743059 /
14/11/2024 18:32:55 | Chg. +0.84 | Volume | Bid14/11/2024 | Ask14/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.08EUR | +2.24% | 5,554 Turnover: 211,962.16 |
-Bid Size: - | -Ask Size: - | 12.5 bill.EUR | 13.21% | 8.44 |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
17/06/2009
Joint press release from OMV Aktiengesellschaft, Daimler AG, The
Linde Group and the State of Baden-...
GlobeNewswire
09/06/2009
Pilot test shows: Less CO2 emissions with new diesel from renewable
energy sources